Federal Funding Cuts for Fentanyl Test Strips: What It Means for Ohio

Federal funding for fentanyl test strips in Ohio has officially ended, leaving public health agencies scrambling to fill the gap. As of June 2026, the Ohio Department of Health has seen its supplies of these life-saving test strips dwindle, according to reporting from WOSU Public Media. This comes at a critical moment — overdose deaths have fallen nearly 50% since 2023, per Stateline, but the drug supply is becoming more dangerous with the emergence of new adulterants like medetomidine.

What Happened to the Funding?

The Trump administration prohibited the use of federal funds for fentanyl test strips, reversing a harm reduction tool that had been widely adopted. The Ohio Department of Health, which distributed test strips through local health departments and community organizations, is now warning that its stock is running low. Without new funding, these strips — which allow people to check if their drugs contain fentanyl — may soon be unavailable.

Here’s the thing: fentanyl test strips aren’t just a personal safety tool. They’re a public health intervention. By letting someone know their cocaine or heroin is laced with fentanyl, they can adjust their dose, use with a buddy, or seek help. In our experience at Recovery Institute of Ohio, we’ve seen how these small strips can be a gateway to conversations about treatment.

Ohio’s Overdose Decline: A Silver Lining?

Despite these funding cuts, there is some good news. A Stateline report from March 2026 shows that opioid overdose deaths across the U.S. have dropped by nearly 50% since 2023. Ohio has mirrored this trend, thanks in part to expanded access to naloxone and increased funding for treatment programs. As we discussed in our article on Ohio Secures $100 Million in Federal SOS Funding to Fight Substance Use, state and federal investments are making a difference.

But this progress is fragile. Federal funding cuts to test strips could reverse these gains. Dr. Mark Hurst, former medical director of the Ohio Department of Mental Health and Addiction Services, has noted that “harm reduction tools like test strips are essential to maintaining the momentum we’ve built.”

The New Threat: Medetomidine in the Drug Supply

Just as we’re losing one harm reduction tool, a new danger is emerging. According to a CDC Health Alert Network advisory from April 2026, the veterinary sedative medetomidine — often called “rhino tranq” — is increasingly being found in the illegal fentanyl supply. Medetomidine can cause profound sedation, bradycardia, and a severe withdrawal syndrome that may require intensive care.

“Medetomidine can cause profound sedation, bradycardia, and hypotension. Stopping medetomidine following regular use may lead to severe withdrawal, similar to clonidine withdrawal, with symptoms including hypertension, anxiety, nausea, vomiting, and fluctuating alertness.” — CDC Health Alert Network

Medetomidine is not detected by standard fentanyl test strips, which means even if someone tests their drugs, they may not know this sedative is present. That’s why we need broader drug checking technologies, such as mass spectrometry — but they’re more expensive and less accessible.

What This Means for Ohio Communities

For Ohioans in Columbus, Cleveland, Cincinnati, and beyond, this funding cut hits close to home. Many local harm reduction organizations rely on state supplies to distribute test strips at syringe service programs and community events. Without them, people who use drugs are left to navigate a more toxic supply blind.

A 2025 study in the Journal of Substance Use and Addiction Treatment found that fentanyl test strips reduced overdose risk by 30% among people who used them consistently. Losing access to these strips could lead to an uptick in fatalities, especially as new adulterants like medetomidine spread.

Meanwhile, Ohio has been a leader in harm reduction innovation. The state has expanded mobile treatment units and drug courts, as we explored in our coverage of Ohio Supreme Court decisions affecting opioid litigation. But without federal support for test strips, these efforts become harder.

Alternatives: How to Stay Safe Without Federal Funding

So what can Ohioans do now? First, know that naloxone remains widely available and can reverse opioid overdoses. You can get it at most pharmacies without a prescription. Second, consider using drug checking services that go beyond fentanyl strips. Some community organizations offer mail-in testing for a broader range of substances.

Third, if you or someone you love is struggling, don’t wait. Treatment works. At Recovery Institute of Ohio, we offer comprehensive programs that address addiction as a chronic disease, not a moral failing. From medical detox to outpatient counseling, we’re here to help.

And let’s be clear: abstinence isn’t the only path. Harm reduction saves lives, and every life saved is a chance at recovery. We need to advocate for funding restoration at the federal level. In the meantime, reach out to your local health department or a harm reduction organization to find out what resources are still available.

Conclusion: Recovery Is Possible

The end of federal funding for fentanyl test strips in Ohio is a setback, but it’s not the end of the story. Overdose deaths have been cut in half — that’s real progress. We can’t let funding decisions undo that. Every person deserves the chance to get help, whether through a test strip, a naloxone kit, or a treatment bed.

If you’re in Ohio and need support, don’t hesitate. Call us at Recovery Institute of Ohio today. Our team is ready to listen, to help, and to walk this road with you. Recovery is possible — and it starts with reaching out.